Our Enterprise

The Global CEO Initiative on Alzheimer’s Disease (CEOi)

Share:

CEOi

The Global CEO Initiative on Alzheimer’s Disease (CEOi), founded in 2013, is an organization of private-sector leaders who have joined together to provide business leadership in the fight against Alzheimer’s. The CEOi believes that, during this era of aging populations, it will take visionary, coordinated, goal-oriented leadership of public and private leaders working together to solve our greatest challenges. It is convened by UsAgainstAlzheimer’s.

Insights from Lausanne V   Lausanne podcast

Our members and collaborators

AARP
AC Immune
Alzheimer's Disease International Logo
Amgen
Axovant Logo
Bank of America
Biogen
Dementia Discovery Fund Logo
Eisai
GE
GAP Logo
Home Instead Senior Care Logo
Janssen United States Logo
Lilly Logo
Novartis Logo
OECD Logo
Optum Labs
Otsuka in the U.S. Logo
Roche Logo
Swiss Confederation Logo
Takeda Logo

Insights from Lausanne V

The Lausanne Workshop is the world’s leading stage for global dialogue on how to speed new innovations in treatment and care to those who will be impacted by Alzheimer’s disease. It is also a platform for governments, industry, academia and international organizations to drive towards our goal of stopping this disease.

Read More

We are also pleased to share the first-ever Lausanne podcast. The podcast focuses on issues shared during the workshop that will impact access to future treatments and diagnostics. You will hear from payers, patients, industry and other access experts. There are certainly challenges ahead, but also opportunities – and more work to be done.